Precision Biosciences (DTIL) Other Non Operating Income (2018 - 2026)

Precision Biosciences (DTIL) has 9 years of Other Non Operating Income data on file, last reported at -$9.4 million in Q1 2026.

• Other Non Operating Income for Q1 2026 came in at -$9.4 million, down 705.43% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.3 million (down 120.15% YoY), and the FY2025 annual result was $5.5 million, down 83.38% from the prior year.
• Other Non Operating Income retreated to -$9.4 million in Q1 2026 per DTIL's latest filing, from $6.8 million in the prior quarter.
• Over five years, Other Non Operating Income peaked at $12.8 million in Q1 2024 and troughed at -$9.4 million in Q1 2026.
• A 5-year average of $1.4 million and a median of $96000.0 in 2023 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2022 and 2024: Other Non Operating Income tumbled 6270.83% in 2022, then soared 8861.46% in 2024.
• A 5-year view of Other Non Operating Income shows it stood at -$7.3 million in 2022, then soared by 119.9% to $1.5 million in 2023, then surged by 691.96% to $11.5 million in 2024, then tumbled by 41.3% to $6.8 million in 2025, then tumbled by 238.37% to -$9.4 million in 2026.
• Business Quant data shows DTIL's Other Non Operating Income at -$9.4 million in Q1 2026, $6.8 million in Q4 2025, and -$1.1 million in Q3 2025.